Delivery Order SPE2DB24D1007-SPE2DB24FCARQ

Award Date 9/27/24
Potential Completion Date 10/21/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $7,792.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of IBRANCE 125 MG CAPSULE 21S. This contract has an ultimate completion date of September 17, 2024 and was awarded on August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several multi-million dollar Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical...
This contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract award, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,792.08, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,796.30, is for the delivery of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product, with a period of performance through March 26, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,127.13 firm fixed-price delivery order is for the supply of IBRANCE 100 MG CAPSULE 21S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a $7,792.08 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities from AmerisourceBergen to support military...
This is a $16,236.16 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of IBRANCE 125MG CAP 21S, a specialty medication. The contract has an ultimate completion date of May 2, 2025 and was awarded on April 11, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,118.08 firm-fixed-price delivery order contract is for the supply of IBRANCE 125 MG CAPSULE 21S, a specialty pharmaceutical product. The contract has an ultimate completion date of May 5, 2025 and was awarded on April 14, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,484.74, is for the delivery of IBRANCE 125 MG CAPSULE 21S to DLA. It is a firm-fixed price, delivery order contract with a completion date of May 10, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,061.38, is for the delivery of IBRANCE 125 MG CAPSULE 21S, a prescription medication. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB24FCARQ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a $7,792.08 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG CAPSULE 21S. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by October 21, 2024.

Generated 12/27/24, 9:18 AM